Uncategorized
Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
NEW YORK--(BUSINESS WIRE)--Ophthotech announced completion of recruitment for its Phase 2b clinical trial of Zimura® for patients with geographic atrophy secondary to dry AMD.